We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Epigallocatechingallate (EGCG) in Cardiac AL Amyloidosis (EpiCardiAL)

This study is currently recruiting participants.
Verified February 2016 by Giampaolo Merlini, IRCCS Policlinico S. Matteo
Sponsor:
ClinicalTrials.gov Identifier:
NCT01511263
First Posted: January 18, 2012
Last Update Posted: February 25, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Giampaolo Merlini, IRCCS Policlinico S. Matteo
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Study Completion Date: No date given
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)